Aeolus Pharmaceuticals, Inc. (AOLS) - OTCQB
Company Description
Aeolus Pharmaceuticals is developing a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed, with funding from the U.S. Department of Health and Human Services, as a... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States